Brassica napus Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Cruciferae; Brassicaceae. |
| Habitat | Cultivated in Punjab, Bengal and Bihar. |
| English | Mustard, Indian Rape. |
| Ayurvedic | Krishna-Sarshapa, Raajakshavaka, Kattaka, Katusneha, Tantubha, Siddhaartha, Siddhaarthaka, Siddhaartha-sita, Rakshogna. (White variety of Sarshapa is also equated with Siddhaartha. Asita and Rakta seed varieties are reddish; Gaur and Siddhaartha are whitish.) |
| Unani | Kaali Sarson. |
| Action | Emollient, diuretic, anticatarrhal. |
| Taxonomic Cohort | Genus Brassica (5 documented species); Family Cruciferae (18 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Brassica napus (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Cruciferae; Brassicaceae (primary family classification: Cruciferae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Cultivated in Punjab, Bengal and Bihar.
Across classical and vernacular Indian systems of medicine, Brassica napus is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Mustard, Indian Rape; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Krishna-Sarshapa, Raajakshavaka, Kattaka, Katusneha, Tantubha, Siddhaartha, Siddhaarthaka, Siddhaartha-sita, Rakshogna. (White variety of Sarshapa is also equated with Siddhaartha. Asita and Rakta seed varieties are reddish; Gaur and Siddhaartha are whitish.); in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Kaali Sarson. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Brassica napus are: Emollient, diuretic, anticatarrhal. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Brassica napus establish the following evidence base: The oil gave brassino steroid—brasinolide. Seeds gave a antithyroid compound, 5-vinyl-2-oxazolidinethone; thioglucosides and thioglucosinolates. The seed oil is said to dissolves gallstone.

Botanical Reference 1: Rapeseed — Botanical specimen

Botanical Reference 2: Rapeseed — Botanical specimen

Botanical Reference 3: Brassica napus — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Brassica comprises 5 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Brassica alba (Action: Stimulant to gastric mucosa, increases pancreatic secretions; emetic (used in…); Brassica campestris rapa (Action: Stimulant, diuretic, emetic, rubefacient, counter-irritant. Used externally for…); Brassica juncea (Action: Raai is a substitute for Mustard. Antidysenteric, stomachic, diaphoretic…); Brassica nigra (Action: Seeds are used for treating coryza with thin excoriating discharge with…). Comparing Brassica napus alongside its congeners in genus Brassica highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Cruciferae encompasses 18 documented medicinal species (0.99% of the 1,814-species flora). Other representative medicinal members of Cruciferae include: Anastatica hierochuntica Linn. (Jericho Rose), Armoracia lapathifolia (Horseradish), Brassica alba (Siddhaartha), Brassica campestris rapa (Sarshapa), Capsella bursa-pastoris (Shepherd’s Purse). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 18 medicinal species of family Cruciferae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Brassica napus follow the plant-part modalities specified under its therapeutic action (Emollient, diuretic, anticatarrhal), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Brassica napus integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.